$SN

SharkNinja, Inc.

2
1
1

No SEC Form 4 filings for $SN in the last 30 days.

See all $SN insider activity →
Med

TD Cowen maintains Buy rating on SharkNinja, $230 price target

TD Cowen reaffirmed a Buy rating and $230 price target for SharkNinja, suggesting a 15.8% upside from the last close. The firm cited strong product innovation and significant market penetration potential as key growth drivers, according to the analyst note.

Smith & Nephew merger talks with J&J orthopaedics unit collapse over CEO role, FT reports

Smith & Nephew's merger talks with Johnson & Johnson's orthopaedics unit collapsed over disagreement on the CEO role, according to the Financial Times. The deal would have valued the unit at up to $22 billion, nearly double Smith & Nephew's market cap. Both companies were aligned on financial terms but disagreed on leadership. Smith & Nephew's former CEO left in 2019 over pay demands.

SN sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 4 news stories mentioning SN (SharkNinja, Inc.). Coverage has skewed bullish: 2 bullish, 1 neutral, and 1 bearish.

Recent SN coverage spans financial news, earnings and mergers & acquisitions.

What's driving SN

AlphAI scores every news story that mentions SN with an AI model for sentiment and relevance, and aggregates insider trades from SharkNinja, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SN

Score
$SNHighAI 8/10

Smith & Nephew merger talks with J&J orthopaedics unit collapse over CEO role, FT reports

Smith & Nephew's merger talks with Johnson & Johnson's orthopaedics unit collapsed over disagreement on the CEO role, according to the Financial Times. The deal would have valued the unit at up to $22 billion, nearly double Smith & Nephew's market cap. Both companies were aligned on financial terms but disagreed on leadership. Smith & Nephew's former CEO left in 2019 over pay demands.

$DELow

This Hacker Let His Rogue AI Program Do All the Work

Researcher Snorre Fagerland of NorForge discovered a hacker using AI tool Cairn to target over 1,200 sites, including Deere, SharkNinja, and Cummins. The hacker's objective was to exploit e-commerce websites. Deere and SharkNinja reported no sensitive data was accessed. Cairn's author denies designing it for malicious use.

$SNMed

UBS sees attractive risk/reward in three European medtech into Q3 results

UBS identifies Convatec, Smith & Nephew, and Sonova as attractive European medtech stocks ahead of Q3 results, citing revenue and earnings growth expectations. Convatec is expected to report 6% organic growth, Smith & Nephew may undergo a strategic review, and Sonova could raise guidance due to market growth and currency tailwinds. UBS provides price targets for each company.

$SNLow

Cookware Launch Could Be A Turning Point For SharkNinja Stock (SN)

SharkNinja (SN) launched Ninja NeverQuit Cookware, a non-toxic ceramic line with a 3-year guarantee, alongside other kitchen essentials. The move aims to diversify its product portfolio and sustain demand. Analysts project $9.0b revenue and $1.1b earnings by 2029, with risks including production costs and marketing spend. Some analysts see higher growth potential, while others caution about margin pressures.

$SNMed

Innovation Engine Drives SharkNinja’s (SN) Sustainable Advantage

Spheria Global Opportunities Fund's Q2 2026 letter highlights SharkNinja (NYSE:SN) as a top contributor. The company, which designs and markets home appliances, reported $6.4B revenue in 2025 with a 40% ROIC. Shares rose after 1Q26 results raised full-year guidance, showing strong consumer demand and market share gains. SN trades at 16.5x FY27 EV/EBIT, with a $750M buyback program. The stock is up 51.03% over the past year but down 6.87% in the past month, with a $24.53B market cap.

$SNHighAI 8/10

Blowout Guidance Sends SharkNinja Shares Higher

SharkNinja (SN) reported Q2 2026 net sales of $1.77B (up 22.2% YoY) and adjusted net income of $178M (up 29%). The company raised full-year 2026 guidance, targeting up to 17% sales growth and $6.55 adjusted EPS. SN shares have risen 56% YTD, supported by institutional demand and strong fundamentals, including 3-year sales growth of 20% and EPS growth of 63.8%.

Related tickers